News

Zacks Investment Research on MSN10h
Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?
Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...
The Pharma Letter1d
Lilly’s $1 billion CRISPR bet: what Verve means for gene editing
Eli Lilly’s (NYSE: LLY) latest acquisition has electrified the biotech world—and sent a clear message that gene editing is no ...
Verve Therapeutics Announces Retention Bonus Program for Executives
Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.
Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.
Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs.
But since Tuesday, when Donald Trump said in a cabinet meeting that imported pharmaceuticals would face a massive levy, ...
Live Science on MSN6d
Experimental treatment for high cholesterol edits DNA in the body to reduce LDL
An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific cholesterol-raising conditions.
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" ...
June In Review: 14 Top Health Press Releases
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and ...